Prosecution Insights
Prosecution Insights
Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
5 pending office actions • 3 art units • 3 examiners • 0 of 5 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Lung Biotechnology Pbc is navigating the Biotechnology & Pharmaceuticals technology area with 5 pending office actions. This volume of activity indicates an active engagement with the patent office across multiple filings. The company is currently working to resolve these matters to secure its pharmaceutical innovations.
The prosecution of these applications is distributed across 3 distinct examiners and 3 distinct art units. This distribution shows that the company's technology is reviewed by multiple specialized departments. Having 3 distinct examiners means the legal team must manage different examination styles, which can lead to varying outcomes across the 5 pending office actions.
ZHU, JIANJIAN is the busiest examiner for this portfolio. This examiner is currently managing 3 busiest examiner pending office actions. Since ZHU, JIANJIAN oversees 3 of the 5 pending office actions, this individual is a key gatekeeper for the company's current intellectual property goals. Successfully addressing the 3 busiest examiner pending office actions under ZHU, JIANJIAN is a critical step in advancing the company's overall portfolio.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| ZHU, JIANJIAN | 3 | 58.8% | +82.4% |
| CANDELARIA, JULIANA IRENE | 1 | 0.0% | +0.0% |
| CHIDIAC, NICHOLAS J | 1 | 54.4% | +34.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18354205 | Methods for Differentiating Stromal Cells or Pericytes | CANDELARIA, JULIANA IRENE | 35d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17410159 | APPARATUS AND METHOD IN 3D PRINTING | CHIDIAC, NICHOLAS J | 15d overdue |
| 18354210 | Methods for Differentiating Epithelial or Basal Cells | ZHU, JIANJIAN | 9d |
| 18227001 | ADVANCED MANUFACTURED TRANSWELL USING SYNTHETIC BIOINK FOR CELL CULTURE AND IN VITRO TISSUE MODELS | ZHU, JIANJIAN | 22d |
| 17738694 | USE OF FUNCTIONALIZED AND NON-FUNCTIONALIZED ECMS, ECM FRAGMENTS, PEPTIDES AND BIOACTIVE COMPONENTS TO CREATE CELL ADHESIVE 3D PRINTED OBJECTS | ZHU, JIANJIAN | — |
| Art Unit | Apps |
|---|---|
| 1631 | 3 |
| 1634 | 1 |
| 1744 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18227001 | ADVANCED MANUFACTURED TRANSWELL USING SYNTHETIC BIOINK FOR CELL CULTURE AND IN VITRO TISSUE MODELS | ZHU, JIANJIAN | 1631 | §103 | Final Rejection | 22d | Pending | Jul 27, 2023 |
| 18354210 | Methods for Differentiating Epithelial or Basal Cells | ZHU, JIANJIAN | 1631 | §103 | Final Rejection | 9d | Pending | Jul 18, 2023 |
| 18354205 | Methods for Differentiating Stromal Cells or Pericytes | CANDELARIA, JULIANA IRENE | 1634 | §103 | Final Rejection | 35d | Pending | Jul 18, 2023 |
| 17738694 | USE OF FUNCTIONALIZED AND NON-FUNCTIONALIZED ECMS, ECM FRAGMENTS, PEPTIDES AND BIOACTIVE COMPONENTS TO CREATE CELL ADHESIVE 3D PRINTED OBJECTS | ZHU, JIANJIAN | 1631 | §103 | Non-Final OA | — | Pending | May 06, 2022 |
| 17410159 | APPARATUS AND METHOD IN 3D PRINTING | CHIDIAC, NICHOLAS J | 1744 | §103 | Final Rejection | 15d overdue | Pending | Aug 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial